Method of transfecting macrophages
AssigneeThe University Court of the University of Edinburgh
InventorsStuart Forbes, Lara Campana, Benjamin Dwyer, Philip Starkey Lewis, John Campbell, Alasdair Fraser
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University Court of the University of Edinburgh
InventorsStuart Forbes, Lara Campana, Benjamin Dwyer, Philip Starkey Lewis, John Campbell, Alasdair Fraser
Estimating the term…
The development of the method of the invention enables the efficient and reproducible production of genetically modified GMP-grade human macrophages. The inventors have described the effects of the method described on cell viability and efficiency of introduction of genetic material into macrophages. Unlike previous methods of introducing genetic material into macrophages, excellent conditions are demonstrated which produce efficient transgene expression, without compromising cell viability. Critically, the method of the invention does not use virus to introduce genetic material, is efficacious on mature cells, are functional with in vitro assay and in vivo transfer in a liver disease model and complies with practices compatible with manufacture and delivery of these cells to patients.
A method of transfecting a human macrophage with genetic material, the method comprising the steps of:
A method according to any preceding claim, wherein the first pulse phase is for a total period of time selected from:
A method according to any preceding claim, wherein the first pulse phase comprises a burst of unipolar pulses and the second pulse phase comprises a burst of unipolar pulses.
A method according to any preceding claim, wherein each pulse in the second pulse phase is selected from:
A method according to any preceding claim, wherein the second pulse phase is for a total period of time selected from:
A method according to any preceding claim, wherein the burst of unipolar pulses are positive or negative pulses.
A method according to any preceding claim, wherein the genetic material comprises a nucleic acid, preferably DNA or RNA.
A method according to any preceding claim, wherein the genetic material comprises one or more nucleic acids encoding one or more genes of interest and/or regulatory elements.
A method according to any preceding claim, wherein the genetic material comprises one or more nucleic acids encoding a homologous or heterologous gene of interest, preferably a heterologous gene of interest.
A method according to any preceding claim, wherein the genetic material is comprised on a vector, preferably a plasmid.
A method according to any preceding claim where the human macrophages are human monocyte derived macrophages.
A method according to any preceding claim, wherein the human macrophage is contacted with genetic material in solution, preferably the solution is conductive, preferably the solution is an electroporation buffer.
A transfected human macrophage comprising a heterologous nucleic acid, wherein the macrophage has a repressed STING pathway and optionally wherein the macrophage has reduced expression of IFN-β.
A population of transfected human macrophages comprising a viability selected from of at least:
Dependencies are inferred from the claim text.